Disclosure 0001193125-26-391985-1

SEC FORM 4

$226,500.00

NewAmsterdam Pharma Co N.V. (NAMS)

Purchase of 10,000 shares at $22.65 per share.

Reporting Person Davidson Michael H. · Officer Title Chief Executive Officer · Transaction Code P

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001193125-26-391985 · filed 2026-09-15 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "NewAmsterdam Pharma Co N.V. (NAMS)." Disclosed 2026-09-15. https://desqlong.com/cards/0001193125-26-391985-1 (retrieved 2026-09-26).